Ignite Creation Date:
2025-12-25 @ 12:13 AM
Ignite Modification Date:
2026-02-23 @ 4:55 AM
Study NCT ID:
NCT03622658
Status:
COMPLETED
Last Update Posted:
2022-03-08
First Post:
2018-07-17
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Efficacy and Safety of Namilumab for Moderate-to-severe Axial Spondyloarthritis
Sponsor:
Izana Bioscience Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-09-06
Start Date Type:
ACTUAL
Primary Completion Date:
2020-02-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-02-04
Completion Date Type:
ACTUAL
First Submit Date:
2018-07-17
First Submit QC Date:
None
Study First Post Date:
2018-08-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2021-12-06
Results First Submit QC Date:
None
Results First Post Date:
2022-03-08
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-01-05
Last Update Post Date:
2022-03-08
Last Update Post Date Type:
ACTUAL